EASTERN BANK has added 111,974 shares of $DGX to their portfolio, per a new SEC 13F filing. This disclosure reflects the funds' holdings for the 06-30-2026 report period. You can see the fund's full portfolio on Quiver Quantitative, and also track the largest institutional owners of $DGX.
QUEST DIAGNOSTICS Hedge Fund Activity
We have seen 459 institutional investors add shares of QUEST DIAGNOSTICS stock to their portfolio, and 538 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- EDGEPOINT INVESTMENT GROUP INC. added 811,320 shares (+95.5%) to their portfolio in Q4 2025, for an estimated $140,788,359
- RTW INVESTMENTS, LP removed 500,000 shares (-100.0%) from their portfolio in Q4 2025, for an estimated $86,765,000
- PACER ADVISORS, INC. removed 450,898 shares (-100.0%) from their portfolio in Q4 2025, for an estimated $78,244,329
- UBS GROUP AG removed 412,114 shares (-37.0%) from their portfolio in Q1 2026, for an estimated $80,766,101
- GOLDMAN SACHS GROUP INC removed 359,969 shares (-21.1%) from their portfolio in Q1 2026, for an estimated $70,546,724
- D. E. SHAW & CO., INC. added 328,734 shares (+inf%) to their portfolio in Q4 2025, for an estimated $57,045,211
- FIDUCIARY MANAGEMENT INC /WI/ removed 325,935 shares (-31.1%) from their portfolio in Q1 2026, for an estimated $63,876,741
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.
QUEST DIAGNOSTICS Insider Trading Activity
QUEST DIAGNOSTICS insiders have traded $DGX stock on the open market 19 times in the past 6 months. Of those trades, 0 have been purchases and 19 have been sales.
Here’s a breakdown of recent trading of $DGX stock by insiders over the last 6 months:
- CATHERINE T. DOHERTY (EVP, Regional Businesses) has made 0 purchases and 8 sales selling 33,788 shares for an estimated $6,964,736.
- J. E. DAVIS (CEO and President) has made 0 purchases and 2 sales selling 20,000 shares for an estimated $4,066,600.
- KARTHIK KUPPUSAMY (SVP, Clinical Solutions) has made 0 purchases and 2 sales selling 10,775 shares for an estimated $2,167,772.
- PATRICK PLEWMAN (SVP for Diagnostic Services) has made 0 purchases and 4 sales selling 9,885 shares for an estimated $2,025,173.
- MICHAEL E PREVOZNIK (SVP & General Counsel) has made 0 purchases and 3 sales selling 5,515 shares for an estimated $1,136,514.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API insider transaction endpoint.
QUEST DIAGNOSTICS Government Contracts
We have seen $135,659,145 of award payments to $DGX over the last year.
Here are some of the awards which we have have seen pay out the most over the last year:
- VISN 7 REFERENCE LAB SERVICES: $8,250,000
- PRIMARY REFERENCE LABORATORY TESTING / COURIER SERVICES / PHLEBOTOMY: $7,899,999
- REFERENCE LAB TESTING - ADD AND EXERCISE OPTION: $3,025,981
- REFERENCE LAB TESTS: $2,748,684
To track government contracts to publicy traded companies, check out Quiver Quantitative's government contracts dashboard. You can access data on government contracts through the Quiver Quantitative API government contracts endpoint.
QUEST DIAGNOSTICS Analyst Ratings
Wall Street analysts have issued reports on $DGX in the last several months. We have seen 1 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Jefferies issued a "Buy" rating on 02/11/2026
To track analyst ratings and price targets for QUEST DIAGNOSTICS, check out Quiver Quantitative's $DGX forecast page.
QUEST DIAGNOSTICS Price Targets
Multiple analysts have issued price targets for $DGX recently. We have seen 9 analysts offer price targets for $DGX in the last 6 months, with a median target of $225.0.
Here are some recent targets:
- Eric Coldwell from Baird set a target price of $229.0 on 04/22/2026
- Luke Sergott from Barclays set a target price of $230.0 on 04/22/2026
- David Macdonald from Truist Securities set a target price of $225.0 on 04/22/2026
- Kevin Caliendo from UBS set a target price of $220.0 on 04/22/2026
- Elizabeth Anderson from Evercore ISI Group set a target price of $210.0 on 04/08/2026
- Ann Hynes from Mizuho set a target price of $235.0 on 02/12/2026
- Tycho Peterson from Jefferies set a target price of $220.0 on 02/11/2026
Note that there may be inaccuracies in these estimates due to filing errors by the funds, parsing errors by us, or other anomalies.
Check out Quiver Quantitative's $DGX ticker page for more data.
